SKILLMAN, N.J., March 3, 2017 -- As a global leader in scientifically driven skincare, Johnson & Johnson Consumer Inc. will present 21 Posters/Abstracts at this year's American Academy of Dermatology (AAD) Annual Meeting in Orlando, FL, March 3-7, 2017. The research includes studies in photoprotection, light therapy for acne, atopic dermatitis and skin microbiome.
"As the research shared at this meeting shows, our scientists study skin health around the world and across a lifetime, from birth to maturity," said Jennifer Zhu, Vice President, Global Beauty R&D at Johnson & Johnson Consumer Inc. "We are committed to developing transformative solutions for common skincare concerns, while adhering to a high standard of clinical efficacy and superior aesthetics."
Of note, Longitudinal Development of the Skin Microbiome During the Neonatal Period (#5324) will be presented at the Late-Breaking Research Forum (Clinical Studies/Pediatric) on Saturday, March 4 from 1:00 – 3:00 PM EST (F072), by Kimberly Capone, PhD, Research Fellow at Johnson & Johnson Consumer Inc.
"Our team is committed to better understanding the role of the microbiome across skin health in a scientifically rigorous way in order to provide truly disruptive approaches to treating skin issues," said Ms. Zhu. "This area of research delivers insights that are relevant to our current business, as well as to our long-term pipeline for both pediatric and adult product development."
Scientific Posters include evaluations of high-SPF sunscreen in real-world settings, as well as an assessment of efficacy, tolerance and mode of action for low-level blue/red light therapy in treatment of acne.
All abstracts will be available for online viewing at the AAD meeting starting 7:00AM EST on March 3, 2017.
Photoprotection: including sunscreen efficacy in actual use settings, Zinc
High-SPF Sunscreen Provides Significant Clinical Benefit in Actual-Use
High-SPF Sunscreen Provides Significantly Better Sunburn Protection
Sun Protection Efficacy by Shade
Modern Sunscreen Formulations Do Not Interfere with Sweating
Microscopic Evaluation of ZnO Sunscreens In Vivo
Zinc Oxide Technology and Superior UVA Protection
Objective and Self-Perceived Anti-Aging Skin Benefits Using a Daily
Acne: including low-level red/blue light therapy, cleansing and skin barrier
A Multicenter, Evaluator-Blinded, Randomized Clinical Study to
Low-Level Red LED Light Inhibits Inflammation Induced by
Utilization of 440 nm Blue Light to Target Propionibacterium acnes for
Dermatologists' Perceptions of Blue-Red Light Acne Phototherapies
Physicians' Attitudes Toward Home-based Devices for Acne
Efficacy and Skin Barrier Benefits of a Novel Acne Cleanser with
Atopic Dermatitis and Severe Dry Skin
A Clinical Trial to Determine the Therapeutic Benefit of an
Compliance Usage Rate and Efficacy of a Coconut-Scented Lotion
A Clinical Trial to Evaluate the Efficacy of an OTC Colloidal Oatmeal Skin Protectant
Hydration and Skin Barrier
A Unique Gel Matrix Moisturizer Delivers Deep Hydration Resulting in
A Multifaceted Calming Serum Significantly Improves Facial Redness and Signs of Aging
A Topical Effervescent Mask Provides Oxygen with Polyhydroxy/Bionic Acids to Help
Advanced, Physician-Strength Retinol Peel Improves the Appearance of Fine Lines,
About Johnson & Johnson Consumer Inc.
Johnson & Johnson Consumer Inc., based in Skillman, NJ, is one of the world's largest consumer health and personal care products companies. Our consumer companies produce many of the world's most trusted brands, among them JOHNSON'S® Baby, BAND-AID®, NEUTROGENA®, TYLENOL®, MOTRIN®, and LISTERINE®. Each one of our consumer businesses embraces innovative science to create products that anticipate consumer needs and create experiences that help them live healthy, vibrant lives.